A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2.

To study the temporal expression of motile structures and protease activity during colon cancer cell invasion by heregulin-beta1 (HRG) and prostaglandin E2 (PGE2), we have developed a three-dimensional spatial model system. HRG and PGE2 each induced the formation of well-organized, three-dimensional structures with empty spaces in the center and stimulated the expression of urokinase plasminogen activator (uPA) with differential localization of membrane-bound uPA at the focal adhesion points and leading edges of the motile cells. A specific cyclooxygenase-2 inhibitor blocked the formation of three-dimensional luminal glandular structures induced by HRG but did not block those induced by PGE2. A specific antagonist of uPA receptor completely blocked the formation of these luminal glandular structures induced by PGE2 and HRG. These findings suggest that HRG-mediated increased invasiveness of colon cancer cells is augmented at least in part by induction of PGE2 and uPA, and this augmentation may involve the formation of three-dimensional invasive structures via the uPA pathway. In addition, the three-dimensional model system presented here may have a wider application to screen the effects of therapeutic compounds and biomolecules on different spatial aspects of colonic biology, including cell growth, motility, invasion, survival, and apoptosis.

[1]  F. Blasi,et al.  Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. , 1991, The American journal of pathology.

[2]  J. Morrow,et al.  Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. , 1998, Cancer research.

[3]  F. Blasi,et al.  Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells , 1995, FEBS letters.

[4]  P. McCrea,et al.  Induction of a Secondary Body Axis in Xenopus by Antibodies to-Catenin , 2002 .

[5]  R. Kumar,et al.  Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. , 2001, Cancer Research.

[6]  A. Aasen,et al.  Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. , 1995, Human pathology.

[7]  C. Stanners,et al.  A colonic tissue architecture assay applied to human colon carcinoma cells , 1997, In Vitro Cellular & Developmental Biology - Animal.

[8]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[9]  J. Mendelsohn,et al.  Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain. , 1989, Cancer research.

[10]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[11]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[12]  R. DuBois,et al.  Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. , 1996, Gastroenterology.

[13]  R. White,et al.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Westfall,et al.  ALTERATIONS IN THE , 1985 .

[15]  M. Mandal,et al.  Regulation of Cyclooxygenase-2 pathway by HER2 receptor , 1999, Oncogene.

[16]  P. McCrea,et al.  Induction of a secondary body axis in Xenopus by antibodies to beta- catenin , 1993, The Journal of cell biology.

[17]  J. Mendelsohn,et al.  Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase* , 1998, The Journal of Biological Chemistry.

[18]  M. Duffy,et al.  The urokinase‐type plasminogen activator system in cancer metastasis: A review , 1997, International journal of cancer.

[19]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Mendelsohn,et al.  Role of 2′-5′-Oligoadenylate Synthetase in γ-Interferon-mediated Growth Inhibition of A431 Cells , 1989 .

[21]  J. Morrow,et al.  Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.

[22]  N. Hynes,et al.  The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.

[23]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[24]  Raymond L. White,et al.  Self-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2 , 1996, Cell.

[25]  J. Bruner,et al.  Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. , 1994, Cancer research.

[26]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[27]  M. Mandal,et al.  Nuclear targeting of Bax during apoptosis in human colorectal cancer cells , 1998, Oncogene.

[28]  G. Petruzzelli,et al.  Prostaglandin E2-protein kinase A signaling and protein phosphatases-1 and -2A regulate human head and neck squamous cell carcinoma motility, adherence, and cytoskeletal organization. , 1996, Prostaglandins.

[29]  Y. S. Kim,et al.  Importance of Desmosome Formation for Glandular Organization of LS174T Human Colon Cancer Cells in Organ Culture , 1989 .

[30]  D. Lawrence,et al.  Immunologic detection of the cellular receptor for urokinase plasminogen activator. , 1994, Clinical immunology and immunopathology.